Back

Antifungal effects of alantolactone on Candida albicans: an in vitro study

Liu, X.; Zhong, L.; Ma, Z.; Sui, Y.; Xie, J.; Ma, T.; Yang, L.

2021-01-26 microbiology
10.1101/2021.01.25.428193 bioRxiv
Show abstract

The human fungal pathogen Candida albicans can cause many kinds of infections, including biofilm infections on medical devices, while the available antifungal drugs are limited to only a few. In this study, alantolactone (Ala) demonstrated antifungal activities against C. albicans, as well as other Candida species, with a MIC of 72 g/mL. Ala could also inhibit the adhesion, yeast-to-hyphal transition, biofilm formation and development of C. albicans. The exopolysaccharide of biofilm matrix and extracellular phospholipase production could also be reduced by Ala treatment. Ala could increase permeability of C. albicans cell membrane and ROS contribute to the antifungal activity of Ala. Overall, the present study suggests that Ala may provide a promising candidate for developing antifungal drugs against C. albicans infections.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Frontiers in Microbiology
○ 427 papers in training set
Top 0.1%
19.0%
Similar papers in this journal
2
Microbiology Spectrum
● 469 papers in training set
Top 1%
8.1%
Similar papers in this journal
3
Frontiers in Cellular and Infection Microbiology
○ 109 papers in training set
Top 0.2%
5.6%
Similar papers in this journal
4
PLOS ONE
● 5266 papers in training set
Top 29%
5.0%
Similar papers in this journal
5
mSphere
● 302 papers in training set
Top 1%
4.4%
Similar papers in this journal
6
Scientific Reports
○ 3612 papers in training set
Top 24%
4.2%
7
Current Microbiology
○ 18 papers in training set
Top 0.1%
3.5%
8
eLife
● 5828 papers in training set
Top 34%
3.3%
50% of probability mass above
9
Journal of Microbiological Methods
○ 13 papers in training set
Top 0.1%
2.5%
10
Microbial Pathogenesis
○ 17 papers in training set
Top 0.1%
2.5%
11
Antimicrobial Agents and Chemotherapy
● 187 papers in training set
Top 1%
2.0%
12
Antibiotics
○ 34 papers in training set
Top 0.4%
2.0%
13
Applied Microbiology and Biotechnology
○ 32 papers in training set
Top 0.4%
1.7%
14
ACS Omega
● 105 papers in training set
Top 2%
1.5%
15
Microbiological Research
○ 22 papers in training set
Top 0.3%
1.5%
16
Environmental Pollution
○ 37 papers in training set
Top 0.8%
1.2%
17
Microorganisms
○ 106 papers in training set
Top 2%
1.2%
18
FEMS Microbiology Letters
◐ 17 papers in training set
Top 0.2%
1.2%
19
Colloids and Surfaces B: Biointerfaces
○ 10 papers in training set
Top 0.2%
1.2%
20
Biomedicines
○ 67 papers in training set
Top 2%
1.2%
21
Applied and Environmental Microbiology
● 339 papers in training set
Top 4%
1.2%
22
Frontiers in Pharmacology
○ 111 papers in training set
Top 2%
1.1%
23
Acta Tropica
○ 13 papers in training set
Top 0.3%
1.1%
24
mBio
● 833 papers in training set
Top 10%
1.1%
25
Biochemistry and Biophysics Reports
○ 30 papers in training set
Top 0.9%
1.0%
26
Pathogens
○ 56 papers in training set
Top 1%
1.0%
27
Fungal Ecology
○ 12 papers in training set
Top 0.2%
0.9%
28
Biomedicine & Pharmacotherapy
○ 42 papers in training set
Top 1%
0.9%
29
ACS Infectious Diseases
● 82 papers in training set
Top 1%
0.9%
30
Heliyon
○ 152 papers in training set
Top 7%
0.9%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.